FindMyKOL
Clinical trialNCT00928538CompletedPhase 4Interventional

Nurse Family Partnership (NFP) Contraceptive Study

NCT00928538 is a phase 4 interventional trial sponsored by Oregon Health and Science University. As of 21 Nov 2026, it is completed. It studies Effective Contraceptive Use, Family Planning and 1 more condition. The registry lists an enrollment of 344 participants at 3 sites in 1 country. The registry lists a start date of 30 Sept 2009 and a primary completion date of 31 May 2013.

SponsorOregon Health and Science University →Enrollment344Effective Contraceptive UseFamily PlanningPregnancy
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00928538
FieldValue
Registry IDNCT00928538
StatusCompleted
PhasePhase 4
Study typeInterventional trial
Lead sponsorOregon Health and Science University
Enrollment344
Registered sites3
Countries1
ConditionsEffective Contraceptive Use, Family Planning and Pregnancy
Start30 Sept 2009
Primary completion31 May 2013
Study completion31 May 2015
Last update posted30 Mar 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether nurses can help at-risk women reduce the incidence of unintended pregnancy by providing them access to hormonal contraceptives in their homes.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Washington, United States3 sites
  • Thurston County Public Health

    Olympia

  • Seattle - King County Public Health

    Seattle

  • Clark County Public Health

    Vancouver

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashington: 3 sitesWA3MontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00928538

Each answer restates registry values shown on this page.

What is NCT00928538?

NCT00928538 is a phase 4 interventional trial sponsored by Oregon Health and Science University. It studies Effective Contraceptive Use, Family Planning and 1 more condition.

Who leads NCT00928538?

The registry names Alan L Melnick, MD, MPH (principal investigator, Oregon Health and Science University) as the overall official.

Where does NCT00928538 run?

The registry lists 3 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT00928538 end?

The registry lists a primary completion date of 31 May 2013 and a study completion date of 31 May 2015. The sponsor last updated the record on 30 Mar 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.